Eli Lilly and Co
BMV:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
BMV:LLY
|
US |
|
A
|
Automatic Data Processing Inc
F:ADP
|
US |
|
S
|
Siemens Energy AG
XMUN:ENR
|
DE |
|
R
|
Rollins Inc
F:RLS
|
US |
|
CK Hutchison Holdings Ltd
HKEX:1
|
HK |
|
B
|
Burlington Stores Inc
SWB:BUI
|
US |
|
Z
|
Ziprecruiter Inc
DUS:47R
|
US |
|
W
|
Westwing Group SE
XBER:WEW
|
DE |
|
L
|
Lam Research Corp
XMUN:LAR
|
US |
|
B
|
Bayer AG
BET:BAYER
|
DE |
|
CK Hutchison Holdings Ltd
F:2CKA
|
HK |
|
T
|
Tenet Healthcare Corp
F:THC1
|
US |
|
Sony Group Corp
NYSE:SONY
|
JP |
|
A
|
Avi Ltd
XBER:IZ6
|
ZA |
|
I
|
Intuit Inc
SWB:ITU
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
DUS:TKD
|
JP |
|
N
|
Nokia Oyj
PAR:NOKIA
|
FI |
|
D
|
Dillard's Inc
F:DL7A
|
US |
|
F
|
Factset Research Systems Inc
XMUN:FA1
|
US |
|
L
|
Las Vegas Sands Corp
BMV:LVS
|
US |
|
P
|
Pearson PLC
DUS:PES
|
UK |
Bankruptcy Probability
Eli Lilly and Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Eli Lilly and Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
624.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
434.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
317.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
222.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
152.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
132.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Eli Lilly and Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Eli Lilly and Co has total debt of 53.1B USD. This includes both short-term (5.3B USD) and long-term (47.9B USD) debt.
You can find a full breakdown on its Balance Sheet.
